Abstract:Two series of novel naphthalin-containing pyrazoline derivatives C1–C14 and D1–D14 have been synthesized and evaluated for their EGFR/HER-2 inhibitory and anti-proliferation activities. Compound D14 displayed the most potent activity against EGFR and A549 cell line (IC50=0.05μM and GI50=0.11μM), being comparable with the positive control Erlotinib (IC50=0.03μM and GI50=0.03μM) and more potent than our previous compounds C0–A (IC50=5.31μM and GI50=33.47μM) and C0–B (IC50=0.09μM and GI50=0.34μM). Meanwhile, compound C14 displayed the most potent activity against HER-2 and MCF-7 cell line (IC50=0.88μM and GI50=0.35μM), being a little less potent than Erlotinib (IC50=0.16μM and GI50=0.08μM) but far more potent than C0–A (IC50=6.58μM and GI50=27.62μM) and C0–B (IC50=2.77μM and GI50=3.79μM). The docking simulation was performed to analyze the probable binding models and the QSAR models were built for reasonable design of EGFR/HER-2 inhibitors at present and in future. The structural modification of introducing naphthalin moiety reinforced the combination of our compounds and the receptor, resulting in progress of bioactivity. Moreover, the replacement of thiourea skeleton by using benzene ring resulted in the slight diversity of the two series towards specific targets.

Synthesis and biological evaluation of novel compounds related to 1-arylnaphthalene lignans and isoquinolines.

Synthesis and Cytotoxicity Evaluation of Some Isoquinoline Derivatives Related to 1-Arylnaphthalene Lignans

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis And Biological Evaluation Of 3-Aryl-Quinoxaline-2-Carbonitrile 1,4-Di-N-Oxide Derivatives As Hypoxic Selective Anti-Tumor Agents

Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives

Design, synthesis and biological evaluation of marine naphthoquinone-naphthol derivatives as potential anticancer agents

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis and biological evaluation of novel 1,6-diaryl pyridin-2(1H)-one analogs.

Design, modification and 3D QSAR studies of novel naphthalin-containing pyrazoline derivatives with/without thiourea skeleton as anticancer agents.

Synthesis and biological evaluation of cytotoxic activity of novel anthracene L-rhamnopyranosides.

Synthesis and Antitumor Activity of 6- and 2-（1-Acylsulfanylalkyl）-5,8-dimethoxy-1,4-naphthoquinones

Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents

Design, Synthesis, and Biological Evaluation of Novel N-γ-carboline Arylsulfonamides As Anticancer Agents.

Synthesis, cytotoxic and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety.

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1h-benzo[d]imidazol-2(3h)-one Derivatives.

Design, Synthesis and Anticancer Activity of Naphthoquinone Derivatives.

Novel 2-amino-1,4-naphthoquinone hybrids: Design, synthesis, cytotoxicity evaluation and in silico studies

Design, Synthesis and 3D-QSAR Study of Cytotoxic Flavonoid Derivatives.

Novel naphthalimide-benzoic acid conjugates as potential apoptosis-inducing agents: design, synthesis, and biological activity.

Novel 4H-1,3,4-oxadiazin-5(6H)-ones with hydrophobic and long alkyl chains: design, synthesis, and bioactive diversity on inhibition of monoamine oxidase, chitin biosynthesis and tumor cell.